Waiting and seeing is not often the strategy employed when it comes to treating breast cancer, but a new clinical trial by the University of California, San Francisco, researchers are doing just that.

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer ...

Some women undergo unnecessary mastectomy and chemotherapy, but a "labyrinth in a chip" could reveal which cancers need ...

At just 36 years old, Constance “Connie” Chavis learned she had stage 3 breast cancer — a combination of ductal carcinoma in ...

Maria Thom discovered she had breast cancer in May 2024 and is now in remission, sharing her story to encourage others ...

A phase 2 study of response-guided neoadjuvant sacituzumab govitecan and pembrolizumab (SG/P) in patients with early-stage triple-negative breast cancer: Results from the NeoSTAR trial. This is an ...

Milspouses have advantages in fighting breast cancer: family, community, and TRICARE. Here's how an Army vet and Air Force ...

This Breast Cancer Awareness Month (October), an oncologist explains the different types of breast cancer, how they are ...

Novel multi-omic biosignature for identification of early-stage invasive breast cancer patients who do and do not benefit from adjuvant radiation treatment after breast conservation surgery. This is ...

Stage 0 cancer, known as carcinoma in situ, marks the earliest stage of cancer development. Abnormal cells are present but ...

A new study published in Cancer Epidemiology, Biomarkers (and) Prevention, a journal of the American Association for Cancer ...